Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes

Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes have?

Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes has 127 citations in the OpenAlex counts ScholarIQ stores.

When was Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes published?

Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes has 2021 year in the ScholarIQ index.

What is the open-access status of Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes?

Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes has gold oa status in the ScholarIQ index.

What is the DOI of Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes?

The DOI for Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes is on the source record.

What is the PMID of Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes?

The PMID for Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes is on the source record.

What is the OpenAlex record for Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes?

The OpenAlex for Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes is on the source record.